Skip to main content
Log in

Revisiting Libman–Sacks Endocarditis: A Historical Review and Update

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Libman–Sacks (LS) endocarditis was first described by Libman and Sacks in 1924, and is characterized by sterile, verrucous valvular lesions with a predisposition for the mitral and aortic valves. It is now regarded as both a cardiac manifestation of systemic lupus erythematosus and, in recent years, of the antiphospholipid syndrome (APS). Though typically mild and asymptomatic, LS endocarditis can lead to significant complications, including severe valvular insufficiency requiring surgery, infective endocarditis, and thromboembolic events, such as stroke and transient ischemic events. Improvements in imaging modalities, particularly in echocardiography, have allowed better estimation of the prevalence of the disease, but further investigation is still needed into its pathogenesis, treatment, and association with APS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Castro J, Balada E, Ordi-Ros J, Vilardell-Tarres M (2008) The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev 7:345–351

    Article  PubMed  CAS  Google Scholar 

  2. Crispin JC, Tsokos GC (2008) Novel molecular targets in the treatment of systemic lupus erythematosus. Autoimmun Rev 7:256–261

    Article  PubMed  CAS  Google Scholar 

  3. Hurst J, von Landenberg P (2008) Toll-like receptors and autoimmunity. Autoimmun Rev 7:204–208

    Article  PubMed  CAS  Google Scholar 

  4. Marmont AM (2008) Will hematopoietic stem cell transplantation cure human autoimmune diseases? J Autoimmun 30:145–150

    Article  PubMed  CAS  Google Scholar 

  5. Shoenfeld Y, Twig G, Katz U, Sherer Y (2008) Autoantibody explosion in antiphospholipid syndrome. J Autoimmun 30:74–83

    Article  PubMed  CAS  Google Scholar 

  6. Tsonis IA, Avrameas S, Moutsopoulos HM (2007) Autoimmunity and pathophysiology. J Autoimmun 29:203–205

    Article  PubMed  CAS  Google Scholar 

  7. Youinou P, Renaudineau Y (2007) The paradox of CD5-expressing B cells in systemic lupus erythematosus. Autoimmun Rev 7:149–154

    Article  PubMed  CAS  Google Scholar 

  8. Libman E, Sacks B (1924) A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 33:701–707

    Google Scholar 

  9. D’Alton JG, Preston DN, Bormanis J, Green MS, Kraag GR (1985) Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 16:512–514

    PubMed  CAS  Google Scholar 

  10. Hojnik M, George J, Ziporen L, Shoenfeld Y (1996) Heart valve involvement (Libman–Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93:1579–1587

    PubMed  CAS  Google Scholar 

  11. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J (1988) Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 319:817–823

    Article  PubMed  CAS  Google Scholar 

  12. Ong ML, Veerapen K, Chambers JB, Lim MN, Manivasagar M, Wang F (1992) Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 34:69–74

    Article  PubMed  CAS  Google Scholar 

  13. Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM (2007) Libman–Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 120:636–642

    Article  PubMed  Google Scholar 

  14. Asherson RA, Hughes GR (1989) The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies. Clin Exp Rheumatol 7:225–228

    PubMed  CAS  Google Scholar 

  15. Espinola-Zavaleta N, Vargas-Barron J, Colmenares-Galvis T, Cruz-Cruz F, Romero-Cardenas A, Keirns C, Amigo MC (1999) Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J 137:973–978

    Article  PubMed  CAS  Google Scholar 

  16. Yamamoto H, Iwade T, Nakano R, Mohri M, Amari Y, Noma M (2007) Images in cardiovascular medicine. Numerous small vegetations revealing Libman–Sacks endocarditis in catastrophic antiphospholipid syndrome. Circulation 116:e531–e535

    Article  PubMed  Google Scholar 

  17. Mandell BF (1987) Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 17:126–141

    Article  PubMed  CAS  Google Scholar 

  18. Doherty NE, Siegel RJ (1985) Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 110:1257–1265

    Article  PubMed  CAS  Google Scholar 

  19. Morin AM, Boyer AS, Nataf P, Gandjbakhch I (1996) Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg 44:313–316

    Article  PubMed  CAS  Google Scholar 

  20. Mraz-Gernhard SM, Bush TM, Riebman JB (2001) Clinical images: Libman–Sacks endocarditis. Arthritis Rheum 44:2111

    Article  PubMed  CAS  Google Scholar 

  21. Moyssakis I, Tzioufas A, Triposkiadis F, Strateges N, Kyriakidis M (2002) Severe aortic stenosis and mitral regurgitation in a woman with systemic lupus erythematosus. Clin Cardiol 25:194–196

    Article  PubMed  Google Scholar 

  22. Hoffer E, Itoua M, Radermecker M, Pierard L (2000) Stenosis of a mechanical mitral prosthetic valve in a patient with systemic lupus erythematosus. Acta Cardiol 55:49–51

    Article  PubMed  CAS  Google Scholar 

  23. Armstrong D, Wright S, McVeigh C, Finch M (2006) Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman–Sacks endocarditis: a case for antibiotic prophylaxis? Clin Rheumatol 25:583–584

    Article  PubMed  Google Scholar 

  24. Tornos MP, Galve E, Pahissa A (1985) Clinical considerations regarding infective Libman–Sacks endocarditis. Int J Cardiol 7:409–412

    Article  PubMed  CAS  Google Scholar 

  25. Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL Jr (2005) Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol 95:1441–1447

    Article  PubMed  Google Scholar 

  26. Pritzker MR, Ernst JD, Caudill C, Wilson CS, Weaver WF, Edwards JE (1980) Acquired aortic stenosis in systemic lupus erythematosus. Ann Intern Med 93:434–436

    PubMed  CAS  Google Scholar 

  27. Kang AH, Graves CR (1999) Libman–Sacks endocarditis in a pregnant woman with acute respiratory distress syndrome. Obstet Gynecol 93:819–821

    Article  PubMed  CAS  Google Scholar 

  28. Appelbe AF, Olson D, Mixon R, Craver JM, Martin RP (1991) Libman–Sacks endocarditis mimicking intracardiac tumor. Am J Cardiol 68:817–818

    Article  PubMed  CAS  Google Scholar 

  29. Taguchi S, Hashimoto K, Sakamoto Y, Okuyama H, Ishii S (2006) A case of mitral valve plasty for Libman–Sacks endocarditis mimicking a cardiac tumor. J Thorac Cardiovasc Surg 132:1465–1467

    Article  PubMed  Google Scholar 

  30. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638

    Article  PubMed  CAS  Google Scholar 

  31. Menard GE (2008) Establishing the diagnosis of Libman–Sacks endocarditis in systemic lupus erythematosus. J Gen Intern Med 23:883–886

    Article  PubMed  Google Scholar 

  32. Roldan CA, Qualls CR, Sopko KS, Sibbitt WL Jr (2008) Transthoracic versus transesophageal echocardiography for detection of Libman–Sacks endocarditis: a randomized controlled study. J Rheumatol 35:224–229

    PubMed  Google Scholar 

  33. Shapiro RF, Gamble CN, Wiesner KB, Castles JJ, Wolf AW, Hurley EJ, Salel AF (1977) Immunopathogenesis of Libman–Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients. Ann Rheum Dis 36:508–516

    Article  PubMed  CAS  Google Scholar 

  34. Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A, Blank M, Sandbank Y, Vilardell-Tarres M, de Torres I, Weinberger A, Asherson RA, Kopolovic Y, Shoenfeld Y (1996) Libman–Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 5:196–205

    Article  PubMed  CAS  Google Scholar 

  35. Bulkey BH, Roberts WC (1975) Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease. Am J Cardiol 35:305–308

    Article  PubMed  CAS  Google Scholar 

  36. Rose AG, Spracklen FH (1987) Double valve disease in systemic lupus erythematosus. Case report and literature review. Am J Cardiovasc Pathol 1:141–144

    PubMed  CAS  Google Scholar 

  37. Brito FA, Tofani ML, Tofani FA, Kakehasi AM, Lanna CC, Carvalho MA (2004) Libman–Sacks endocarditis and oral anticoagulation. Arq Bras Cardiol 82:378–383

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Eric Gershwin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, J.L., Naguwa, S.M., Cheema, G.S. et al. Revisiting Libman–Sacks Endocarditis: A Historical Review and Update. Clinic Rev Allerg Immunol 36, 126–130 (2009). https://doi.org/10.1007/s12016-008-8113-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-008-8113-y

Keywords

Navigation